NASDAQ:ZNTL

Zentalis Pharmaceuticals Stock Insider Trading

etoro logo Buy ZNTL
*Your capital is at risk
$3.72
-0.230 (-5.82%)
At Close: Jun 03, 2026

Zentalis Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 5.99. In total, the insiders bought 21.74M and sold 7.65M ZNTL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
5.99
Buy 21.74M shares
Sell 7.65M shares
76% Buy Activity
Weak Negative Correlation
Buy Signal Medium Confidence
May 26, 2026

Analysis Breakdown:

  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (76% buys).

Historical Insider Trades

Date Type Person Role Amount
May 26, 2026
Buy
Common Stock
A-Award
Campbell Shannon
Director
Director 114 200
Value: $452.2K
May 22, 2026
Buy
Common Stock
J-Other
Campbell Shannon
Director 0
Value: $0
Feb 10, 2026
Sell
Common Stock
S-Sale
Vultaggio Vincent
Pao And Pfo
Officer 6 894
Value: $16.7K
Feb 09, 2026
Sell
Common Stock
S-Sale
Vultaggio Vincent
Pao And Pfo
Officer 3 379
Value: $8K
Feb 09, 2026
Sell
Common Stock
S-Sale
Bruns Ingmar
Chief Medical Officer
Officer 335
Value: $802
Feb 09, 2026
Sell
Common Stock
S-Sale
Eastland Julia Marie
CEO & President
CEO / President 889
Value: $2K
Feb 06, 2026
Sell
Common Stock
S-Sale
Vultaggio Vincent
Pao And Pfo
Officer 29 951
Value: $72.8K
Feb 06, 2026
Sell
Common Stock
S-Sale
Bruns Ingmar
Chief Medical Officer
Officer 2 962
Value: $7K
Feb 06, 2026
Sell
Common Stock
S-Sale
Eastland Julia Marie
CEO & President
CEO / President 7 866
Value: $19.1K
Feb 03, 2026
Sell
Common Stock
S-Sale
Vultaggio Vincent
Pao And Pfo
Officer 556
Value: $1K
Feb 02, 2026
Sell
Common Stock
S-Sale
Vultaggio Vincent
Pao And Pfo
Officer 2 540
Value: $6K
Jan 08, 2026
Buy
Stock Option (Right to Buy)
A-Award
Bucher James B
Chief Legal Officer
Officer 100 000
Value: $284.0K
Jan 08, 2026
Buy
Stock Option (Right to Buy)
A-Award
Vultaggio Vincent
Pao And Pfo
Officer 100 000
Value: $284.0K
Jan 08, 2026
Buy
Stock Option (Right to Buy)
A-Award
Bruns Ingmar
Chief Medical Officer
Officer 365 000
Value: $1.04M
Jan 08, 2026
Buy
Stock Option (Right to Buy)
A-Award
Eastland Julia Marie
CEO & President
CEO / President 775 000
Value: $2.20M
Dec 31, 2025
Buy
Common Stock
P-Purchase
Walters Group
10 Percent Owner
10% Owner 6 459 973
Value: $7.75M
Dec 15, 2025
Buy
Common Stock
Walters Group
10 Percent Owner
10% Owner 0
Value: $0
Dec 15, 2025
Sell
Common Stock, par value $0.001 per share
S-Sale
Matrix Capital Management Company, Lp
10 Percent Owner
10% Owner 7 500 000
Value: $9.98M
Oct 01, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bucher James B
Chief Legal Officer
Officer 400 000
Value: $616.0K
Oct 01, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bucher James B
Chief Legal Officer
Officer 400 000
Value: $616.0K
Sep 18, 2025
Buy
Common Stock
J-Other
Bucher James B
Officer
Officer 0
Value: $0
Sep 18, 2025
Buy
Common Stock
J-Other
Bucher James B
Officer
Officer 0
Value: $0
Jun 17, 2025
Buy
Common Stock
A-Award
Walker Luke Nathaniel
Director
Director 57 603
Value: $86.4K
Jun 17, 2025
Buy
Common Stock
A-Award
Skvarka Jan
Director
Director 57 603
Value: $86.4K
Jun 17, 2025
Buy
Common Stock
A-Award
Johnson David Michael
Director
Director 57 603
Value: $86.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ZENTALIS PHARMACEUTICALS INC.
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE